STIM (neurostar.com) Earnings per share growth this year

Official company branding of Neuronetics, Inc (STIM)

Neuronetics, Inc. (STIM) is expanding its business selling neuron stimulation systems, supplementing revenue with high-margin software. The shift in earnings per share compared to last year illustrates the market response, fixing the metric's value at 50.80. Success is based on the uniqueness of NeuroStar in treating depression, while the growth of the installed equipment base activates operating leverage through the sale of session cards.

STIM (NeuroStar) Earnings per share growth in current year history from 07/04/2022 to 11/10/2026

Financial and market metric breakdowns for Neuronetics, Inc. (STIM)

- stock value and consensus price forecast:
Market Price Neuronetics Inc.|STIM - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Neuronetics, Inc|STIM - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share Neuronetics|STIM - Company Book Value|Market Cap to Net Assets Ratio neurostar.com|STIM - Company Total Assets
- debt and solvency information:
Debt to Capital Neuronetics, Inc.|STIM - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio neurostar.com|STIM - Company Aggregate Debts|Debts to Net Assets Neuronetics, Inc|STIM - Company Long-Term Debts|Company Current Liabilities Neuronetics|Quick Ratio neurostar.com
- net income and valuation multiples indicators:
STIM - Company Net Income|Expected Profit Neuronetics, Inc.|STIM - Price to Earnings Ratio|Future Price to Earnings Multiple Neuronetics, Inc|STIM - PEG Multiple|Company Value to EBITDA Neuronetics, Inc|STIM - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Neuronetics|STIM - Net earnings per share for the last 12 months|Quarterly EPS earnings growth neurostar.com|STIM - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Neuronetics, Inc.
Fundamental valuation:STIM - Neuronetics Inc.
Signature product of Neuronetics Inc.

To assess the return on capital for Neuronetics, Inc. (STIM), the balance between operational efficiency and the pressure of marketing expenses is critical. The YoY net income per share growth trend reflects the business's ability to scale earnings per share despite competition from pharmacology and the risks of reduced insurance reimbursements. Growth in this indicator confirms the resilience of the business model and the effectiveness of cost management.

Direct competitors

Earnings per share growth rate in current year Boston Scientific Corp (BSX)|EW (Edwards Lifesciences Corp) - Earnings growth in current year|Earnings per share growth this year RMD (ResMed Corporation)|Net earnings per share growth this year PODD (Insulet Corporation)|ZBH (Zimmer Biomet Holdings, Inc.) - Earnings per share increase in current year|Earnings per share growth in current year CooperCompanies COO|ALGN - Net earnings per share growth this year|Globus Medical Corp - Earnings growth in current year|Earnings per share growth rate in current year TransMedics Group|ATEC: Earnings growth in current year|Earnings per share growth this year AORT|ENOV (Enovis) - Earnings growth in current year|Integra LifeSciences Corp (IART) - Expected net earnings per share growth this year|Earnings growth in current year ESTA|Net earnings per share growth this year iLet Bionic Pancreas BBNX|Earnings growth in current year IRMD (IRADIMED CORPORATION)|Earnings growth in current year embecta.com EMBC|TNDM - Earnings per share growth in current year|AXGN: Earnings per share growth in current year|SIBN (SI-BONE Corp) - Net earnings per share growth this year|Orthofix Corp - Earnings per share increase in current year|BVS (Bioventus Inc.) - Earnings growth in current year|Earnings per share growth rate in current year OrthoPediatrics Inc. KIDS|Earnings per share growth in current year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per share change in current year|Carlsmed Corp - Net earnings per share growth this year|Earnings growth in current year RxSight Ophthalmic RXST|ClearPoint - Earnings growth in current year|Expected net earnings per share growth this year stereotaxis.com STXS|Sight Sciences (SGHT) - Earnings per share growth in current year|Earnings per share trend in current year OBIO (orchestrabiomed.com)|Earnings per share growth in current year Anika Therapeutics Inc.|Net earnings per share growth this year InspireMD Inc. (NSPR)|Earnings growth in current year ZJYL|VANI - Earnings per share growth rate in current year|Earnings per share growth in current year Xtant Medical XTNT|NMTC: Earnings per share growth this year|MODD: Net earnings per share growth this year|Myomo Inc - Net earnings per one share growth for the current year|Envoy Medical, Inc. (COCH) - Earnings per share growth in current year|Earnings per share growth this year VVOS|NVNO (enVVeno Medical Corp.) - Earnings growth in current year|Earnings per share growth rate in current year SINTX Technologies SINT|Net earnings per share growth this year TNON (Tenon Medical, Inc)|Earnings growth in current year Lifeward Ltd. (LFWD)|Earnings per share growth in current year Autonomix Medical AMIX|Earnings per share increase in current year IVF|BBLG - Earnings per share growth in current year|Earnings per share growth rate in current year Axonics Inc.|Biolase, Inc. (BIOL) - Earnings per share growth in current year|Earnings per share growth this year DYNT|FNA (Paragon 28 Inc.) - Earnings growth in current year|Earnings per share growth rate in current year INVO Bio INVO